azacitidine and netropsin

azacitidine has been researched along with netropsin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eguchi, M; Eguchi-Ishimae, M; Gao, W; Inukai, T; Ishii, E; Iwabuki, H; Sugita, K; Tauchi, H; Wu, Z; Yagi, C	1

Other Studies

1 other study(ies) available for azacitidine and netropsin

Article	Year
HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia. British journal of haematology, 2015, Volume: 171, Issue:5 Topics: Azacitidine; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; DNA-Binding Proteins; Drug Synergism; Gene Knockdown Techniques; Genes, p16; Histone-Lysine N-Methyltransferase; HMGA2 Protein; Humans; Infant; MicroRNAs; Molecular Targeted Therapy; Myeloid-Lymphoid Leukemia Protein; Netropsin; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Transcriptional Elongation Factors; Up-Regulation	2015

Article

Year

HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.

British journal of haematology, 2015, Volume: 171, Issue:5

Topics: Azacitidine; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; DNA-Binding Proteins; Drug Synergism; Gene Knockdown Techniques; Genes, p16; Histone-Lysine N-Methyltransferase; HMGA2 Protein; Humans; Infant; MicroRNAs; Molecular Targeted Therapy; Myeloid-Lymphoid Leukemia Protein; Netropsin; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Transcriptional Elongation Factors; Up-Regulation

2015